Author: Bill Snyder
Sep. 20, 2019—Vanderbilt University’s F. Peter (Fred) Guengerich, PhD, and Elaine Sanders-Bush, PhD, are among 22 prominent scientists named this week to the inaugural class of fellows of the American Society for Pharmacology and Experimental Therapeutics (ASPET).
Sep. 19, 2019—Advances in genetics are leading to new ways to treat cardiomyopathies — devastating heart muscle disorders that lead to heart failure.
Sep. 13, 2019—Phase 1 trial results in new approach to combat the chikungunya
Sep. 12, 2019—A course that provides biomedical scientists-in-training at Vanderbilt University School of Medicine with the essentials of data science has won second place in the 2019 Innovations in Research and Research Education Award program sponsored by the American Association of Medical Colleges (AAMC).
Sep. 9, 2019—Vanderbilt's Master’s Program in Biomedical Sciences prepares students for a broad array of health professional careers.
Sep. 5, 2019—According to a new study, the tiny zebrafish may hold the secret to regenerating damaged retinas in humans.
Sep. 4, 2019—Researchers at Vanderbilt University Medical Center are partnering with the Dutch biopharmaceutical firm Batavia Biosciences and Nashville-based IDBiologics to bring to the clinic a highly potent Zika virus neutralizing antibody they isolated three years ago.
Aug. 29, 2019—Ten years on, a unique summer research program at Vanderbilt University Medical Center designed primarily for rural high school students with limited resources is achieving its goal of increasing the diversity of the nation’s scientists and engineers.